145 related articles for article (PubMed ID: 35080278)
1. Paediatric mycosis fungoides - characteristics, management and outcomes with particular focus on the folliculotropic variant.
Reiter O; Amitay-Laish I; Oren-Shabtai M; Feinmesser M; Ben-Amitai D; Hodak E
J Eur Acad Dermatol Venereol; 2022 May; 36(5):671-679. PubMed ID: 35080278
[TBL] [Abstract][Full Text] [Related]
2. Recommendations for treatment in folliculotropic mycosis fungoides: report of the Dutch Cutaneous Lymphoma Group.
van Santen S; van Doorn R; Neelis KJ; Daniëls LA; Horváth B; Bruijn MS; Sanders CJG; van Rossum MM; de Haas ERM; Veraart JCJM; Bekkenk MW; Vermeer MH; Willemze R
Br J Dermatol; 2017 Jul; 177(1):223-228. PubMed ID: 28132406
[TBL] [Abstract][Full Text] [Related]
3. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
[TBL] [Abstract][Full Text] [Related]
4. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
[TBL] [Abstract][Full Text] [Related]
5. Folliculotropic mycosis fungoides: Clinical characteristics, treatments, and long-term outcomes of 53 patients in a tertiary hospital.
Kalay Yildizhan I; Sanli H; Akay BN; Uzundere C; Okcu Heper A
Dermatol Ther; 2020 Jul; 33(4):e13585. PubMed ID: 32410323
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides.
Wieser I; Wang C; Alberti-Violetti S; Lyons G; Tran C; Talpur R; Duvic M
Arch Dermatol Res; 2017 Aug; 309(6):453-459. PubMed ID: 28516243
[TBL] [Abstract][Full Text] [Related]
7. Folliculotropism Does Not Affect Overall Survival in Mycosis Fungoides: Results from a Single-Center Cohort and Meta-Analysis.
Giberson M; Mourad A; Gniadecki R
Dermatology; 2017; 233(4):320-325. PubMed ID: 29169156
[TBL] [Abstract][Full Text] [Related]
8. The different faces of mycosis fungoides: results of a single-center study.
Sidiropoulou P; Nikolaou V; Marinos L; Voudouri D; Komini E; Economidi A; Rigopoulos D; Stratigos A
Int J Dermatol; 2020 Mar; 59(3):314-320. PubMed ID: 31782525
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis.
Phan K; Ramachandran V; Fassihi H; Sebaratnam DF
JAMA Dermatol; 2019 Mar; 155(3):335-341. PubMed ID: 30698622
[TBL] [Abstract][Full Text] [Related]
10. Stage-dependent Increase in Expression of miR-155 and Ki-67 and Number of Tumour-associated Inflammatory Cells in Folliculotropic Mycosis Fungoides.
Atzmony L; Moyal L; Feinmesser M; Gorovitz B; Hirshberg A; Amitay-Laish I; Prag-Naveh H; Barzilai A; Hodak E
Acta Derm Venereol; 2020 Aug; 100(15):adv00230. PubMed ID: 32556361
[TBL] [Abstract][Full Text] [Related]
11. Bath Psoralen-ultraviolet A and Narrowband Ultraviolet B Phototherapy as Initial Therapy for Early-stage Mycosis Fungoides: A Retrospective Cohort of 267 Cases at the University of Toronto.
Almohideb M; Walsh S; Walsh S; Shear N; Alhusayen R
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):604-612. PubMed ID: 28711574
[TBL] [Abstract][Full Text] [Related]
12. Clinical Staging and Prognostic Factors in Folliculotropic Mycosis Fungoides.
van Santen S; Roach RE; van Doorn R; Horváth B; Bruijn MS; Sanders CJ; de Pooter JC; van Rossum MM; de Haas ER; Veraart JC; Bekkenk MW; Vermeer MH; Willemze R
JAMA Dermatol; 2016 Sep; 152(9):992-1000. PubMed ID: 27276223
[TBL] [Abstract][Full Text] [Related]
13. Syringotropic Mycosis Fungoides: A Variant of Folliculotropic or a Distinct Subtype of Adnexotropic Mycosis Fungoides?
Nussbaum D; Eleryan M; Samaan C; Glass F; Prussick R
J Drugs Dermatol; 2022 Dec; 21(12):1362-1364. PubMed ID: 36468959
[TBL] [Abstract][Full Text] [Related]
14. Role of bath psoralen plus ultraviolet A in early-stage mycosis fungoides.
Pavlotsky F; Hodak E; Ben Amitay D; Barzilai A
J Am Acad Dermatol; 2014 Sep; 71(3):536-41. PubMed ID: 24836546
[TBL] [Abstract][Full Text] [Related]
15. Phototherapy for mycosis fungoides.
Dogra S; Mahajan R
Indian J Dermatol Venereol Leprol; 2015; 81(2):124-35. PubMed ID: 25751327
[TBL] [Abstract][Full Text] [Related]
16. Two distinct variants of mycosis fungoides (MF): Folliculotropic MF and erythrodermic MF.
Kamijo H; Sugaya M
J Dermatol; 2019 Dec; 46(12):1136-1140. PubMed ID: 31625194
[TBL] [Abstract][Full Text] [Related]
17. Folliculotropic Mycosis Fungoides in 20 Korean Cases: Clinical and Histopathologic Features and Response to Ultraviolet A-1 and/or Photodynamic Therapy.
Jang MS; Jang JY; Park JB; Kang DY; Lee JW; Lee TG; Hwangbo H; Suh KS
Ann Dermatol; 2018 Apr; 30(2):192-201. PubMed ID: 29606817
[TBL] [Abstract][Full Text] [Related]
18. New insights into folliculotropic mycosis fungoides (FMF): A single-center experience.
Hodak E; Amitay-Laish I; Atzmony L; Prag-Naveh H; Yanichkin N; Barzilai A; Kershenovich R; Feinmesser M
J Am Acad Dermatol; 2016 Aug; 75(2):347-55. PubMed ID: 27245278
[TBL] [Abstract][Full Text] [Related]
19. Paediatric Mycosis Fungoides: Clinical Variants, Treatment Modalities and Response to Therapy.
Mirmovich Morvay O; Ramon M; Khamaysi Z; Avitan-Hersh E
Acta Derm Venereol; 2023 Jul; 103():adv6557. PubMed ID: 37449370
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]